Michael Burry Closes Hedge Fund After AI Short Bets
Michael Burry, famed 'Big Short' investor, closes Scion Asset Management after controversial bets against AI leaders Palantir and Nvidia. Read the full story.
Category : Search result: pharmaceutical stocks
Barbados Launches US$200M Life Sciences Hub
Barbados partners with EarlyHealth Group to build a US$200 million life sciences hub, positioning the island as the Caribbean's premier pharmaceutical and research centre.
TSX climbs as tech and energy sectors boost markets
Canada's S&P/TSX composite gained strength from technology and energy sectors while U.S. markets showed mixed results. Manufacturing sales surged 3.3% in September, reaching highest level since February.
Asian shares tumble following Wall Street's AI stock concerns
Asian markets declined sharply as investor anxiety over AI stock valuations and persistent interest rate worries sparked global selloff. Key market movements and economic indicators analyzed.
Northland Power cuts dividend, shares sink 20%
Northland Power announces 50% dividend reduction amid financial challenges, causing stock to plummet over 20%. Key details on strategic review and market impact.
Nvidia and AI Stocks Drive U.S. Market Volatility
U.S. stock markets experience significant fluctuations as Nvidia and artificial intelligence companies show continued volatility. Stay informed on market trends.
Cisco Shares Climb on Strong AI-Fuelled Demand
Cisco shares surge as the company reports robust demand for its AI-powered networking equipment, signaling a major shift in corporate infrastructure spending. Discover the details behind this tech rally.
AMD stock climbs on strong growth targets
AMD shares jumped significantly as investors cheered the company's ambitious long-term growth projections. The semiconductor giant outlined aggressive expansion plans during investor day.
Pfizer wins $10B obesity drug takeover battle
Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.
Tech Stock Selloff Triggers Global Market Retreat
Global markets stumble as tech stocks lead Wall Street lower, with investors eyeing inflation data and Federal Reserve signals. Discover why markets are nervous and what's next for investors.
Nova Leap Health Posts Record Q3 2025 Results
Nova Leap Health Corp announces historic financial performance with record revenue and profitability, marking the strongest quarter in company history with impressive year-over-year growth.
Trump's Plan to Slash Obesity Drug Prices
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.
Lightspeed Q2 Revenue Jumps 25%, Raises Guidance
Montreal-based tech giant Lightspeed Commerce reports strong Q2 2024 results with revenue climbing to $230.3 million, prompting increased full-year financial guidance amid global expansion.
Trump's Drug Price Plan Backfires, Helps Democrats
Former President Trump's proposal to regulate Medicare drug prices faces unexpected consequences as Democrats leverage it to attack Republican positions on healthcare, creating political turmoil.
Trump Reveals Deal to Lower Obesity Drug Costs
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giant to make obesity drugs more affordable and accessible across the United States.
Cineplex Posts $12M Q3 Profit Amid Cinema Recovery
Cineplex posts surprising $12 million third-quarter profit as Canadian moviegoers return to theaters, though revenue still trails pre-pandemic levels. Get the full financial breakdown.
Trump Obesity Drug Deal Boosts Pharma Stocks
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
Michael Burry Bets Big on China Stocks & Gold
The legendary investor who predicted the 2008 financial crisis is back with massive new positions in Chinese stocks and gold ETFs, alongside cryptic market warnings.
Seal Diet Study Reignites NL Fisheries Debate
New research reveals seals are consuming large quantities of cod, reigniting the contentious discussion about seal management in Atlantic Canada's struggling fishing industry.
Mink Ventures Expands Ontario Gold Exploration Portfolio
Mink Ventures announces strategic expansion of its gold exploration portfolio in Ontario, including new property acquisitions and upcoming fieldwork programs targeting high-potential mineralization.
Suncor Shares Jump After Earnings Beat and Production Boost
Calgary-based energy leader Suncor delivers impressive Q2 results, exceeding analyst forecasts and raising production guidance, sending shares skyrocketing.
Meta Stock Tumbles on AI Spending Fears
Meta Platforms faces investor backlash as ambitious AI infrastructure investments trigger stock decline. Discover how Zuckerberg's AI ambitions are reshaping the company's financial landscape.
Suncor Hikes Dividend, Beats Earnings Expectations
Suncor Energy delivers impressive Q4 results, beating earnings expectations and rewarding shareholders with a substantial dividend increase amid rising oil prices and operational improvements.
Cameco Boosts Dividend Despite Quarterly Loss
Saskatoon-based uranium giant Cameco demonstrates confidence with dividend hike amid small quarterly loss, signaling strong long-term nuclear outlook.
Global Markets Retreat as Tech Stocks Decline
Global stock markets face pressure as major technology companies experience significant declines, dragging down U.S. indices and creating ripple effects across international markets.
Kinross Gold Shines with Strong Q3 2025 Results
Kinross Gold Corporation delivers impressive third-quarter 2025 performance with increased production, lower costs, and robust cash flow generation. Discover how their strategic operations are driving exceptional results in the gold mining sector.
Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board
Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.
AI Stock Rally Fades as Global Markets Slump
Global markets retreat as early AI-driven gains evaporate. Asian and European stocks decline while investors await key economic data and Federal Reserve signals.
West Red Lake Gold Strikes High-Grade Bonanza
Breaking exploration results from West Red Lake Gold Mines show exceptional high-grade gold intersections in the Lower Austin Zone, signaling strong growth potential for this promising Canadian gold project.
Canadian Stocks Beat U.S. Markets Amid Trump Uncertainty
Discover why Canadian equities are beating U.S. markets as Trump's potential return creates investor uncertainty. Analysis of TSX vs S&P 500 performance and sector outlook.
Page 3 of 4